Most people find fisetin through longevity content, where it is framed entirely as a senolytic. Its older and arguably better-characterized activity is something different: fisetin is a mast cell stabilizer. Mast cells are the immune cells that release histamine, and a substantial body of cell and animal work shows fisetin interferes with that release. This has nothing to do with senescence, and it is worth understanding on its own terms, including its limits.
Key Takeaways
- In IgE-stimulated mast cells, fisetin inhibited β-hexosaminidase release (the standard degranulation readout) and reduced IL-4 and TNF-α expression, while suppressing Syk, Gab2, LAT, and ERK1/2 signaling.
- Fisetin also lowered expression of the FcεRI α-subunit, the receptor that IgE actually binds to, and suppressed passive cutaneous anaphylaxis in sensitized mice.
- A 2023 study found fisetin relieves chronic urticaria-like symptoms in mice by antagonizing MRGPRX2, a mast cell receptor involved in non-IgE “pseudo-allergic” reactions that standard antihistamines do not address.
- In a mouse food allergy model, oral fisetin at 1 to 3 mg/kg/day reduced anaphylactic manifestations, blood eosinophils, OVA-specific IgE, IL-4, and intestinal degranulated mast cell counts.
- All of this is cell culture and rodent work. No human trial has tested fisetin for urticaria, food allergy, allergic rhinitis, or any allergic condition.
How Fisetin Interferes With an Allergic Reaction
The classic allergic cascade runs like this: IgE antibodies coat mast cells by binding the FcεRI receptor; an allergen cross-links those antibodies; a signaling chain fires through Syk kinase and calcium influx; and the mast cell dumps its granules of histamine and other mediators into the tissue. Antihistamines act at the last step, blocking histamine at its receptor after release. A mast cell stabilizer acts earlier, preventing the release.
A 2017 study mapped where fisetin intervenes. In IgE and antigen-stimulated RBL-2H3 mast cells, fisetin inhibited β-hexosaminidase release, the standard marker of degranulation, and reduced IL-4 and TNF-α messenger RNA. Probing the signaling chain, fisetin reduced activated Syk, Gab2, LAT, and ERK1/2, plus NF-κB and STAT3 in the ear tissue of mice undergoing passive cutaneous anaphylaxis. It also lowered expression of the FcεRI α-subunit itself, meaning fewer receptors available for IgE to bind. Consistent with the cell data, fisetin markedly suppressed the cutaneous anaphylaxis reaction in sensitized mice[1].
The Chronic Urticaria Finding Is the More Novel One
Chronic urticaria, persistent hives, frustrates a lot of patients precisely because antihistamines often only partly help. One reason is that not all mast cell activation runs through IgE. MRGPRX2 is a receptor on skin mast cells that triggers degranulation in response to substance P and various drugs, a pathway sometimes called pseudo-allergic, and it is elevated in the skin mast cells of chronic urticaria patients.
A 2023 study tested fisetin against exactly this. In mouse models of chronic urticaria driven by substance P, fisetin prevented urticaria-like symptoms. In human LAD2 mast cells and MRGPRX2-expressing HEK293 cells, fisetin suppressed calcium mobilization and degranulation by binding MRGPRX2, and downregulated phosphorylated Akt, P38, NF-κB, and PLCγ[2]. Hitting a pathway that current antihistamines do not is a genuinely interesting mechanistic result. It is also still a mouse and cell study.
Food Allergy, at Doses That Are Actually Low
A 2019 study is unusual in the fisetin literature for using doses in a range a supplement could plausibly approximate. Mice sensitized to ovalbumin received oral fisetin at 1 or 3 mg/kg/day. Fisetin attenuated anaphylactic manifestations, decreased blood eosinophil count, serum OVA-specific IgE, and IL-4, reduced total and degranulated mast cell counts in the intestine, raised IFN-γ, and abolished the intestinal histopathological changes the allergen caused[3].
Two caveats keep this in proportion. Mouse-to-human dose conversion is not a simple body-weight scaling, so 3 mg/kg in a mouse does not translate to 3 mg/kg in a person. And this is a model where the allergen exposure was controlled by the experimenters, which is nothing like living with a food allergy where an accidental exposure can be life-threatening.
Fisetin Is Not an Alternative to Anything That Works
This section matters more than the mechanism sections. Anaphylaxis is treated with epinephrine. Nothing in this literature suggests fisetin substitutes for an epinephrine auto-injector, allergen avoidance, or prescribed allergy treatment, and there is no human evidence it reduces reaction severity in people. The flavonoid anti-allergy literature goes back to at least 2007[4] without producing an approved flavonoid allergy therapy, which is itself informative about how far promising in vitro mast cell data tends to travel.
Quercetin, fisetin’s structural cousin, has considerably more mast cell research behind it and is the flavonoid usually studied for this purpose. If you are interested in the flavonoid-and-mast-cell idea specifically, that is the better-characterized option, and it has the same fundamental limitation: promising preclinical data, thin human evidence.
Practical Takeaway
Fisetin’s mast cell activity is real, mechanistically detailed, and reproduced across multiple models, including one pathway that conventional antihistamines miss. It has also never been tested in a human with an allergic condition. If you have chronic hives or a food allergy, this is an interesting research direction to watch and a conversation to have with an allergist, not a reason to change how you manage a condition that can put you in an emergency room.
References
- Antiallergic effect of fisetin on IgE-mediated mast cell activation in vitro and on passive cutaneous anaphylaxis (PCA). J Nutr Biochem (2017). PMID 28797929
- Fisetin alleviates chronic urticaria by inhibiting mast cell activation via MRGPRX2. J Pharm Pharmacol (2023). PMID 37410860
- Fisetin and telmisartan each alone or in low-dose combination alleviate OVA-induced food allergy in mice. Pharmacol Rep (2019). PMID 30826574
- Flavonoids and related compounds as anti-allergic substances. Allergol Int (2007). PMID 17384531
- Fisetin, a Natural Polyphenol, Ameliorates Endometriosis Modulating Mast Cells Derived NLRP-3 Inflammasome Pathway and Oxidative Stress. Int J Mol Sci (2023). PMID 36982152
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
